Circulating fibroblast activation protein and dipeptidyl peptidase 4 in rheumatoid arthritis and systemic sclerosis.
Premarani SinnathuraiWendy LauAna Julia Vieira de RibeiroWilliam W BachovchinHelen EnglertGraydon HoweDavid SpencerNicholas ManoliosMark D GorrellPublished in: International journal of rheumatic diseases (2016)
No association was found between cFAP and RA or SSc. Plasma DPP4 was decreased in RA and SSc when compared with controls. cDPP4 and cFAP correlated negatively with inflammatory markers and there were no significant correlations with disease characteristics in this RA cohort.